JH-RE-06
| CAS No. | 1361227-90-8 | Cat. No. | BCP48872 |
| Name | JH-RE-06 | ||
| Synonyms | JH-RE06; JH-RE 06; JHRE-06; JHRE06; JHRE 06; | ||
| Formula | C20H16Cl3N3O4 | M. Wt | 468.72 |
| Description | JH-RE-06 is a potent REV1 inhibitor. JH-RE-06 disrupts mutagenic TLS by preventing recruitment of mutagenic POL ζ. JH-RE-06 targets a nearly featureless surface of REV1 that interacts with the REV7 subunit of POL ζ. JH-RE-06 inhibits mutagenic TLS and enhances cisplatin-induced toxicity in cultured human and mouse cell lines. Co-administration of JH-RE-06 with cisplatin suppresses the growth of xenograft human melanomas in mice, establishing a framework for developing TLS inhibitors as a novel class of chemotherapy adjuvants. | ||
| Pathways | Cell Cycle/DNA Damage | ||
| Targets | DNA/RNA Synthesis | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.